Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joela Mathews

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Neurology and Therapy|March 23, 2022
Cladribine Tablets for Relapsing-Remitting Multiple Sclerosis: A Clinician's ReviewGavin Giovannoni, Joela Mathews
Multiple Sclerosis and Related Disorders|June 16, 2024
Reconciling lesions, relapses and smouldering associated worsening: A unifying model for multiple sclerosis pathogenesisNiraj Mistry, Jeremy Hobart, David Rog, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 14, 2025
A comparison of JC virus assay performance provided with originator and biosimilar natalizumabJames Varley, Rahma Beyrouti, Richard Nicholas, et al.
Annals of Clinical and Translational Neurology|July 12, 2017
Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosisCesar Alvarez-Gonzalez, Ashok Adams, Joela Mathews, et al.
BMC Neurology|March 28, 2024
Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of IrelandAshvin Kuri, David E Henshall, Daoud Chaudhry, et al.
Multiple Sclerosis and Related Disorders|March 7, 2020
Socioeconomic status and disease-modifying therapy prescribing patterns in people with multiple sclerosisSaúl Reyes, Sebastian Suarez, Kimberley Allen-Philbey, et al.
Practical Neurology|July 8, 2022
Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelinesRuth Dobson, David Rog, Caroline Ovadia, et al.
Practical Neurology|July 8, 2020
Protecting people with multiple sclerosis through vaccinationSaúl Reyes, Mary Ramsay, Shamez Ladhani, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2018
Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?Zhifeng Mao, César Álvarez-Gonzalez, Stefania De Trane, et al.
Therapeutic Advances in Neurological Disorders|November 13, 2023
Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosisKimberley Allen-Philbey, Stefania De Trane, Amy MacDougall, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Neurology and Therapy|March 23, 2022
Cladribine Tablets for Relapsing-Remitting Multiple Sclerosis: A Clinician's ReviewGavin Giovannoni, Joela Mathews
Multiple Sclerosis and Related Disorders|June 16, 2024
Reconciling lesions, relapses and smouldering associated worsening: A unifying model for multiple sclerosis pathogenesisNiraj Mistry, Jeremy Hobart, David Rog, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 14, 2025
A comparison of JC virus assay performance provided with originator and biosimilar natalizumabJames Varley, Rahma Beyrouti, Richard Nicholas, et al.
Annals of Clinical and Translational Neurology|July 12, 2017
Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosisCesar Alvarez-Gonzalez, Ashok Adams, Joela Mathews, et al.
BMC Neurology|March 28, 2024
Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of IrelandAshvin Kuri, David E Henshall, Daoud Chaudhry, et al.
Multiple Sclerosis and Related Disorders|March 7, 2020
Socioeconomic status and disease-modifying therapy prescribing patterns in people with multiple sclerosisSaúl Reyes, Sebastian Suarez, Kimberley Allen-Philbey, et al.
Practical Neurology|July 8, 2022
Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelinesRuth Dobson, David Rog, Caroline Ovadia, et al.
Practical Neurology|July 8, 2020
Protecting people with multiple sclerosis through vaccinationSaúl Reyes, Mary Ramsay, Shamez Ladhani, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2018
Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?Zhifeng Mao, César Álvarez-Gonzalez, Stefania De Trane, et al.
Therapeutic Advances in Neurological Disorders|November 13, 2023
Disease activity 4.5 years after starting cladribine: experience in 264 patients with multiple sclerosisKimberley Allen-Philbey, Stefania De Trane, Amy MacDougall, et al.
Pageof 2